Observational studyEye (London, England)2026
Long-term clinical outcomes of dome-shaped macula: a contralateral eye comparison.
Observational study in Eye (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesTo assess the long-term clinical and anatomical characteristics of eyes with dome-shaped macula (DSM) through a contralateral eye comparison in patients with unilateral involvement.
methodsThis retrospective observational study included 33 highly myopic patients with unilateral DSM. Eyes with DSM (Group 1) were compared with contralateral eyes without DSM (Group 2). All patients were followed for at least three years. Uncorrected and best-corrected visual acuity (UCVA and BCVA), refractive parameters, axial length (AL), central macular thickness (CMT), subfoveal choroidal thickness (SFCT), complications, and applied treatments were analysed.
resultsUCVA was significantly better in Group 1 than in Group 2 at both presentation and the 3-year follow-up (p = 0.01 and p = 0.03, respectively). Spherical equivalent was significantly lower in Group 1 at both time points (p = 0.03 and p = 0.02, respectively). AL was shorter in Group 1 than in Group 2, although the difference was not significant; however, axial elongation over time was greater in Group 2. CMT and SFCT were significantly higher in Group 1 at presentation and follow-up. Subretinal fluid was present in 21 eyes in Group 1 at presentation. During follow-up, myopic macular neovascularisation developed in 4 eyes in Group 1 and 2 eyes in Group 2, without a significant intergroup difference.
conclusionsEyes with DSM demonstrate distinct refractive and anatomical features, including lower spherical equivalent, relatively shorter AL, and increased CMT and SFCT. Subretinal fluid is a common finding, while no significant association was found between DSM and myopic macular neovascularisation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.